Table 1 Baseline characteristics and inflammatory biomarker profiles of the patients with stable coronary artery disease who encountered acute myocardial infarction during follow-up (Subject group) and those patients without cardiovascular events during follow-up (Control group).

From: Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease

 

Control group

(n = 50)

Subject group

(n = 25)

P value

Age, years

64.4 ± 9.9

63.2 ± 14.9

0.694

Male, n (%)

46 (92.0%)

23 (92.0%)

1.000

Waist circumference, cm

93.4 ± 8.6

93.8 ± 7.4

0.807

Hip circumference, cm

97.8 ± 6.5

100.1 ± 5.3

0.102

Waist-hip ratio

1.0 ± 0.1

0.9 ± 0.1

0.223

Height, cm

165.2 ± 5.6

167.1 ± 7.7

0.292

Body weight, kgw

70.0 ± 10.0

72.8 ± 11.8

0.326

BMI

25.6 ± 3.4

26.0 ± 3.3

0.662

SBP, mmHg

132.1 ± 17.6

135.2 ± 15.0

0.439

DBP, mmHg

76.4 ± 11.2

80.4 ± 15.3

0.255

Hypertension, n (%)

25 (50.0%)

12 (48.0%)

0.870

Diabetes mellitus, n (%)

27 (54.0%)

12 (48.0%)

0.624

History of smoking, n (%)

25 (50.0%)

15 (60.0%)

0.413

History of drinking, n (%)

11 (22.0%)

2 (8.0%)

0.198

Anticoagulants, n (%)

0 (0.0%)

1 (4.0%)

0.333

Antiplatelet, n (%)

48 (96.0%)

23 (92.0%)

0.597

ACEI/ARB, n (%)

30 (60.0%)

15 (60.0%)

1.000

B-blocker, n (%)

27 (54.0%)

14 (56.0%)

0.870

CCB, n (%)

27 (54.0%)

10 (40.0%)

0.253

Diuretics, n (%)

6 (12.0%)

4 (16.0%)

0.723

Statins, n (%)

30 (60.0%)

18 (72.0%)

0.307

Total cholesterol, mg/dL

165.8 ± 31.6

157.3 ± 29.5

0.257

Triglyceride, mg/dL

124.8 ± 67.6

128.7 ± 75.3

0.829

HDLC, mg/dL

42.5 ± 11.7

38.7 ± 10.6

0.173

LDLC, mg/dL

96.3 ± 29.7

93.1 ± 24.3

0.625

hs-CRP, mg/dL

0.2 ± 0.3

0.3 ± 0.2

0.684

Adiponectin, ng/mL

18.3 ± 34.0

14.1 ± 10.4

0.421

Lp-PLA2, ng/mL

80.3 ± 121.0

128.2 ± 189.8

0.295

IL 6, pg/mL

2.6 ± 2.9

2.7 ± 2.7

0.891

TNF-α, pg/mL

4.6 ± 4.7

5.1 ± 5.5

0.738

MMP-9, ng/mL

472.2 ± 291.0

416.1 ± 358.5

0.530

NT-pro BNP, pg/mL

366.8 ± 555.9

521.5 ± 734.9

0.359

  1. ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; CCB, calcium channel blocker; DBP, diastolic blood pressure; hs-CRP, high-sensitivity C-reactive protein; IL 6, interleukin 6; Lp-PLA2, lipoprotein-associated phospholipase A2; MMP-9, matrix metalloproteinase-9; NT-pro BNP, N-terminal pro b-type natriuretic peptide; SBP, systolic blood pressure; TNF-α, tumor necrosis factor alpha.
Back to article page